170 related articles for article (PubMed ID: 34581627)
1. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative.
Puijk RS; Ahmed M; Adam A; Arai Y; Arellano R; de Baère T; Bale R; Bellera C; Binkert CA; Brace CL; Breen DJ; Brountzos E; Callstrom MR; Carrafiello G; Chapiro J; de Cobelli F; Coupé VMH; Crocetti L; Denys A; Dupuy DE; Erinjeri JP; Filippiadis D; Gangi A; Gervais DA; Gillams AR; Greene T; Guiu B; Helmberger T; Iezzi R; Kang TW; Kelekis A; Kim HS; Kröncke T; Kwan S; Lee MW; Lee FT; Lee EW; Liang P; Lissenberg-Witte BI; Lu DS; Madoff DC; Mauri G; Meloni MF; Morgan R; Nadolski G; Narayanan G; Newton I; Nikolic B; Orsi F; Pereira PL; Pua U; Rhim H; Ricke J; Rilling W; Salem R; Scheffer HJ; Sofocleous CT; Solbiati LA; Solomon SB; Soulen MC; Sze D; Uberoi R; Vogl TJ; Wang DS; Wood BJ; Goldberg SN; Meijerink MR
Radiology; 2021 Dec; 301(3):533-540. PubMed ID: 34581627
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.
Cohen R; Vernerey D; Bellera C; Meurisse A; Henriques J; Paoletti X; Rousseau B; Alberts S; Aparicio T; Boukovinas I; Gill S; Goldberg RM; Grothey A; Hamaguchi T; Iveson T; Kerr R; Labianca R; Lonardi S; Meyerhardt J; Paul J; Punt CJA; Saltz L; Saunders MP; Schmoll HJ; Shah M; Sobrero A; Souglakos I; Taieb J; Takashima A; Wagner AD; Ychou M; Bonnetain F; Gourgou S; Yoshino T; Yothers G; de Gramont A; Shi Q; André T;
Eur J Cancer; 2020 May; 130():63-71. PubMed ID: 32172199
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Gourgou-Bourgade S; Cameron D; Poortmans P; Asselain B; Azria D; Cardoso F; A'Hern R; Bliss J; Bogaerts J; Bonnefoi H; Brain E; Cardoso MJ; Chibaudel B; Coleman R; Cufer T; Dal Lago L; Dalenc F; De Azambuja E; Debled M; Delaloge S; Filleron T; Gligorov J; Gutowski M; Jacot W; Kirkove C; MacGrogan G; Michiels S; Negreiros I; Offersen BV; Penault Llorca F; Pruneri G; Roche H; Russell NS; Schmitt F; Servent V; Thürlimann B; Untch M; van der Hage JA; van Tienhoven G; Wildiers H; Yarnold J; Bonnetain F; Mathoulin-Pélissier S; Bellera C; Dabakuyo-Yonli TS
Ann Oncol; 2015 May; 26(5):873-879. PubMed ID: 25725046
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Bellera CA; Penel N; Ouali M; Bonvalot S; Casali PG; Nielsen OS; Delannes M; Litière S; Bonnetain F; Dabakuyo TS; Benjamin RS; Blay JY; Bui BN; Collin F; Delaney TF; Duffaud F; Filleron T; Fiore M; Gelderblom H; George S; Grimer R; Grosclaude P; Gronchi A; Haas R; Hohenberger P; Issels R; Italiano A; Jooste V; Krarup-Hansen A; Le Péchoux C; Mussi C; Oberlin O; Patel S; Piperno-Neumann S; Raut C; Ray-Coquard I; Rutkowski P; Schuetze S; Sleijfer S; Stoeckle E; Van Glabbeke M; Woll P; Gourgou-Bourgade S; Mathoulin-Pélissier S
Ann Oncol; 2015 May; 26(5):865-872. PubMed ID: 25070543
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
Bonnetain F; Bonsing B; Conroy T; Dousseau A; Glimelius B; Haustermans K; Lacaine F; Van Laethem JL; Aparicio T; Aust D; Bassi C; Berger V; Chamorey E; Chibaudel B; Dahan L; De Gramont A; Delpero JR; Dervenis C; Ducreux M; Gal J; Gerber E; Ghaneh P; Hammel P; Hendlisz A; Jooste V; Labianca R; Latouche A; Lutz M; Macarulla T; Malka D; Mauer M; Mitry E; Neoptolemos J; Pessaux P; Sauvanet A; Tabernero J; Taieb J; van Tienhoven G; Gourgou-Bourgade S; Bellera C; Mathoulin-Pélissier S; Collette L
Eur J Cancer; 2014 Nov; 50(17):2983-93. PubMed ID: 25256896
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
Kramar A; Negrier S; Sylvester R; Joniau S; Mulders P; Powles T; Bex A; Bonnetain F; Bossi A; Bracarda S; Bukowski R; Catto J; Choueiri TK; Crabb S; Eisen T; El Demery M; Fitzpatrick J; Flamand V; Goebell PJ; Gravis G; Houédé N; Jacqmin D; Kaplan R; Malavaud B; Massard C; Melichar B; Mourey L; Nathan P; Pasquier D; Porta C; Pouessel D; Quinn D; Ravaud A; Rolland F; Schmidinger M; Tombal B; Tosi D; Vauleon E; Volpe A; Wolter P; Escudier B; Filleron T;
Ann Oncol; 2015 Dec; 26(12):2392-8. PubMed ID: 26371288
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.
Ahmed M; Solbiati L; Brace CL; Breen DJ; Callstrom MR; Charboneau JW; Chen MH; Choi BI; de Baère T; Dodd GD; Dupuy DE; Gervais DA; Gianfelice D; Gillams AR; Lee FT; Leen E; Lencioni R; Littrup PJ; Livraghi T; Lu DS; McGahan JP; Meloni MF; Nikolic B; Pereira PL; Liang P; Rhim H; Rose SC; Salem R; Sofocleous CT; Solomon SB; Soulen MC; Tanaka M; Vogl TJ; Wood BJ; Goldberg SN; ; ; ;
Radiology; 2014 Oct; 273(1):241-60. PubMed ID: 24927329
[TBL] [Abstract][Full Text] [Related]
9. Research Highlight: How to Use Technical and Oncologic Outcomes of Image-Guided Tumor Ablation According to Guidelines by Society of Interventional Oncology and DATECAN?
Lee MW; Rhim H
Korean J Radiol; 2022 Apr; 23(4):385-388. PubMed ID: 35345060
[No Abstract] [Full Text] [Related]
10. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.
Bellera CA; Pulido M; Gourgou S; Collette L; Doussau A; Kramar A; Dabakuyo TS; Ouali M; Auperin A; Filleron T; Fortpied C; Le Tourneau C; Paoletti X; Mauer M; Mathoulin-Pélissier S; Bonnetain F
Eur J Cancer; 2013 Mar; 49(4):769-81. PubMed ID: 23122780
[TBL] [Abstract][Full Text] [Related]
11. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013.
Gillams A; Goldberg N; Ahmed M; Bale R; Breen D; Callstrom M; Chen MH; Choi BI; de Baere T; Dupuy D; Gangi A; Gervais D; Helmberger T; Jung EM; Lee F; Lencioni R; Liang P; Livraghi T; Lu D; Meloni F; Pereira P; Piscaglia F; Rhim H; Salem R; Sofocleous C; Solomon SB; Soulen M; Tanaka M; Vogl T; Wood B; Solbiati L
Eur Radiol; 2015 Dec; 25(12):3438-54. PubMed ID: 25994193
[TBL] [Abstract][Full Text] [Related]
12. Clinical indications for image guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-part III, nerves of the upper limb.
Sconfienza LM; Adriaensen M; Albano D; Allen G; Aparisi Gómez MP; Bazzocchi A; Beggs I; Bignotti B; Chianca V; Corazza A; Dalili D; De Dea M; Del Cura JL; Di Pietto F; Drakonaki E; Facal de Castro F; Filippiadis D; Gielen J; Gitto S; Gupta H; Klauser AS; Lalam R; Martin S; Martinoli C; Mauri G; McCarthy C; McNally E; Melaki K; Messina C; Mirón Mombiela R; Neubauer B; Obradov M; Olchowy C; Orlandi D; Gonzalez RP; Rutkauskas S; Snoj Z; Tagliafico AS; Talaska A; Vasilevska-Nikodinovska V; Vucetic J; Wilson D; Zaottini F; Zappia M; Plagou A;
Eur Radiol; 2020 Mar; 30(3):1498-1506. PubMed ID: 31712960
[TBL] [Abstract][Full Text] [Related]
13. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
[TBL] [Abstract][Full Text] [Related]
14. Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project.
Postema AW; De Reijke TM; Ukimura O; Van den Bos W; Azzouzi AR; Barret E; Baumunk D; Blana A; Bossi A; Brausi M; Coleman JA; Crouzet S; Dominguez-Escrig J; Eggener S; Ganzer R; Ghai S; Gill IS; Gupta RT; Henkel TO; Hohenfellner M; Jones JS; Kahmann F; Kastner C; Köhrmann KU; Kovacs G; Miano R; van Moorselaar RJ; Mottet N; Osorio L; Pieters BR; Polascik TJ; Rastinehad AR; Salomon G; Sanchez-Salas R; Schostak M; Sentker L; Tay KJ; Varkarakis IM; Villers A; Walz J; De la Rosette JJ
World J Urol; 2016 Oct; 34(10):1373-82. PubMed ID: 26892160
[TBL] [Abstract][Full Text] [Related]
15. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
16. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Patient-Reported Outcomes in an Enhanced Recovery Pathway.
Abola RE; Bennett-Guerrero E; Kent ML; Feldman LS; Fiore JF; Shaw AD; Thacker JKM; Gan TJ; Miller TE; Hedrick TL; McEvoy MD; Mythen MG; Bergamaschi R; Gupta R; Holubar SD; Senagore AJ; Wischmeyer PE; Carli F; Evans DC; Guilbert S; Kozar R; Pryor A; Thiele RH; Everett S; Grocott M;
Anesth Analg; 2018 Jun; 126(6):1874-1882. PubMed ID: 29293180
[TBL] [Abstract][Full Text] [Related]
17. Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.
Golan R; Bernstein A; Sedrakyan A; Daskivich TJ; Du DT; Ehdaie B; Fisher B; Gorin MA; Grunberger I; Hunt B; Jiang HH; Kim HL; Marinac-Dabic D; Marks LS; McClure TD; Montgomery JS; Parekh DJ; Punnen S; Scionti S; Viviano CJ; Wei JT; Wenske S; Wysock JS; Rewcastle J; Carol M; Oczachowski M; Hu JC
J Urol; 2018 Jun; 199(6):1488-1493. PubMed ID: 29307684
[TBL] [Abstract][Full Text] [Related]
18. Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-part I, shoulder.
Sconfienza LM; Adriaensen M; Albano D; Allen G; Aparisi Gómez MP; Bazzocchi A; Beggs I; Bignotti B; Chianca V; Corazza A; Dalili D; De Dea M; Del Cura JL; Di Pietto F; Drakonaki E; Facal de Castro F; Filippiadis D; Gielen J; Gitto S; Gupta H; Klauser AS; Lalam R; Martin S; Martinoli C; Mauri G; McCarthy C; McNally E; Melaki K; Messina C; Mirón Mombiela R; Neubauer B; Olchowy C; Orlandi D; Plagou A; Prada Gonzalez R; Rutkauskas S; Snoj Z; Tagliafico AS; Talaska A; Vasilevska-Nikodinovska V; Vucetic J; Wilson D; Zaottini F; Zappia M; Obradov M
Eur Radiol; 2020 Feb; 30(2):903-913. PubMed ID: 31529252
[TBL] [Abstract][Full Text] [Related]
19. Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
Collettini F; Enders J; Stephan C; Fischer T; Baur ADJ; Penzkofer T; Busch J; Hamm B; Gebauer B
Radiology; 2019 Jul; 292(1):250-257. PubMed ID: 31161973
[TBL] [Abstract][Full Text] [Related]
20. Musculoskeletal Oncologic Interventions: Proceedings from the Society of Interventional Radiology and Society of Interventional Oncology Research Consensus Panel.
Kurup AN; Jennings JW; Tutton S; Tam AL; Kelekis A; Wood BJ; Dupuy DE; Napoli A; Park SS; Robinson SI; Rose PS; Soulen MC; White SB; Callstrom MR
J Vasc Interv Radiol; 2021 Jul; 32(7):1089.e1-1089.e9. PubMed ID: 34210477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
